Alerts will be sent to your verified email
Verify Email
INFLUX
|
Influx Healthtech
|
Sudarshan Pharma Ind
|
Quest Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
61.78 % | 11.77 % | 30.21 % |
|
5yr Avg Net Profit Margin
|
10.21 % | 2.0 % | 7.37 % |
|
Price to Book
|
10.6 | 6.0 | 0.0 |
|
P/E
|
28.66 | 49.43 | 12.02 |
|
5yr Avg Cash Conversion Cycle
|
-66.58 Days | 121.83 Days | 1.67 Days |
|
5yr Average Interest Coverage Ratio
|
988.18 | 2.61 | 14.47 |
|
5yr Avg ROCE
|
82.15 % | 23.07 % | 39.56 % |
|
5yr Avg Operating Profit Margin
|
15.28 % | 4.55 % | 11.77 % |
|
5 yr average Debt to Equity
|
0.06 | 0.99 | 0.32 |
|
5yr CAGR Net Profit
|
24.67 % | 42.99 % | 72.53 % |
|
5yr Average Return on Assets
|
24.24 % | 3.51 % | 10.78 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 57.39 % | 66.21 % |
|
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | -31.89 % | 0.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
|
Influx Healthtech
|
Sudarshan Pharma Ind
|
Quest Laboratories
|
|---|